Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 23 citing articles:

Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson’s disease: an overview and update on new developments
Mohammad Yasin Zamanian, Rosario Mireya Romero‐Parra, Afsaneh Soltani, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 6, pp. 5455-5464
Closed Access | Times Cited: 40
Are Therapies That Target α-Synuclein Effective at Halting Parkinson’s Disease Progression? A Systematic Review
A. Rodger, Maryam N. ALNasser, Wayne G. Carter
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11022-11022
Open Access | Times Cited: 19
Cannabidiol - a friend or a foe?
Bianca-Maria Tihăuan, Tatiana Onisei, Walter Slootweg, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107036-107036
Open Access
Cannabis as a Source of Approved Drugs: A New Look at an Old Problem
Adi Gabarin, Ludmila Yarmolinsky, Arie Budovsky, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7686-7686
Open Access | Times Cited: 12
Neuroprotective and Anti-Inflammatory Effects of Pioglitazone on Parkinson's Disease: A Comprehensive Narrative Review of Clinical and Experimental Findings
Mohammad Yasin Zamanian, Ermias Mergia Terefe, Niloofar Taheri, et al.
CNS & Neurological Disorders - Drug Targets (2022) Vol. 22, Iss. 10, pp. 1453-1461
Closed Access | Times Cited: 19
An Investigation of the Neurotoxic Effects of Malathion, Chlorpyrifos, and Paraquat to Different Brain Regions
Ekramy Elmorsy, Ayat B. Al‐Ghafari, Huda A. Al Doghaither, et al.
Brain Sciences (2022) Vol. 12, Iss. 8, pp. 975-975
Open Access | Times Cited: 15
vNN model cross validation towards Accuracy, Sensitivity, Specificity and kappa performance measures of β-caryophyllene using a restricted-unrestricted applicability domain on Artificial Intelligence & Machine Learning approach based in-silico prediction
K. Krishnaveni, M. Sabitha, M. Murugan, et al.
Journal of Drug Delivery and Therapeutics (2022) Vol. 12, Iss. 1-S, pp. 123-131
Open Access | Times Cited: 12
Cannabinoids as Potential Cancer Therapeutics: The Concentration Conundrum
Nurgul Carkaci‐Salli, Wesley M. Raup‐Konsavage, Deepkamal Karelia, et al.
Cannabis and Cannabinoid Research (2023) Vol. 9, Iss. 4, pp. e1159-e1169
Closed Access | Times Cited: 7
Differential Effects of Paraquat, Rotenone, and MPTP on Cellular Bioenergetics of Undifferentiated and Differentiated Human Neuroblastoma Cells
Ekramy Elmorsy, Ayat B. Al‐Ghafari, Huda A. Al Doghaither, et al.
Brain Sciences (2023) Vol. 13, Iss. 12, pp. 1717-1717
Open Access | Times Cited: 7
Natural products targeting cellular processes common in Parkinson's disease and multiple sclerosis
Xuxu Xu, Chaowei Han, Pengcheng Wang, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 5
Randomized controlled trials on the use of cannabis-based medicines in movement disorders: a systematic review
Panteleimon Oikonomou, Wolfgang H. Jost
Journal of Neural Transmission (2022) Vol. 129, Iss. 10, pp. 1247-1256
Closed Access | Times Cited: 9
Alcohol Triggers the Accumulation of Oxidatively Damaged Proteins in Neuronal Cells and Tissues
Anusha W. Mudyanselage, Buddhika C. Wijamunige, Artur Kocoń, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 580-580
Open Access | Times Cited: 1
Neuroprotective Effects of Cannabispirenone A against NMDA-Induced Excitotoxicity in Differentiated N2a Cells
Sonia Thapa, Yedukondalu Nalli, Ajeet Singh, et al.
Oxidative Medicine and Cellular Longevity (2024) Vol. 2024, pp. 1-11
Open Access | Times Cited: 1
Outcomes and Outlooks of Therapeutic Application of Modulators of Endogenous Cannabinoid System in Parkinson's Disease
Л. Г. Хаспеков, С. Н. Иллариошкин
(2024)
Open Access | Times Cited: 1
Therapeutic Application of Modulators of Endogenous Cannabinoid System in Parkinson’s Disease
Л. Г. Хаспеков, С. Н. Иллариошкин
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8520-8520
Open Access | Times Cited: 1
Immunomodulatory properties of cannabinoids; a molecular insight
Reuben Maghembe, Jackson T. Mollel, Stephen S. Nyandoro
Elsevier eBooks (2024), pp. 185-226
Closed Access | Times Cited: 1
Zebrafish as an Animal Model in Cannabinoid Research
Joanna Izabela Lachowicz, Aleksandra Szopa, Katarzyna Ignatiuk, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10455-10455
Open Access | Times Cited: 4
Identification of minimum essential therapeutic mixtures from cannabis plant extracts by screening in cell and animal models of Parkinson’s disease
Michael G. Morash, Jessica Nixon, Lori M. N. Shimoda, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Effects of cannabinoids in Parkinson’s disease animal models: a systematic review and meta-analysis
Berzenn Urbi, Yunjoo Lee, Ian Hughes, et al.
BMJ Open Science (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 5
Advice to People with Parkinson’s in My Clinic: Cannabis
Maria Eliza Freitas, Susan H. Fox
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 4, pp. 873-881
Open Access
Cannabis and Parkinson’s Disease
Ivan A. Ross
Springer eBooks (2023), pp. 513-567
Closed Access
Beyond conventional therapy: cannabinoids as an alternative in parkinson's disease
Lincoln Basilio Alves, Ana Lúcia Basílio Carneiro, Caroline Moraes Tapajós Bolzani, et al.
OBSERVATÓRIO DE LA ECONOMÍA LATINOAMERICANA (2023) Vol. 21, Iss. 12, pp. 27077-27101
Open Access
IS CANNABINOID AN ALTERNATIVE TO THE CURRENT PHARMACOLOGICAL TREATMENT FOR THE REDUCTION OF PARKINSON'S DISEASE SYMPTOMS?
Augusto Alexandre Corrêa Mansur Telhada, Paulo Roberto Hernandes Júnior, Natan de Oliveira Faria Machado, et al.
International Journal of Health Science (2022) Vol. 2, Iss. 27, pp. 2-10
Open Access
Page 1

Scroll to top